Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families

被引:41
作者
Durocher, Francine [1 ]
Labrie, Yvan
Soucy, Penny
Sinilnikova, Olga
Labuda, Damian
Bessette, Paul
Chiquette, Jocelyne
Laframboise, Rachel
Lepine, Jean
Lesperance, Bernard
Ouellette, Genevieve
Pichette, Roxane
Plante, Marie
Tavtigian, Sean V.
Simard, Jacques
机构
[1] Ctr Hosp Univ Quebec, Oncol & Mol Endocrinol Res Ctr, Canc Genom Lab, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Quebec City, PQ G1V 4G2, Canada
[3] Hospices Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitutionnelle Canc Frequent, Lyon, France
[4] Hop St Justine, Ctr Cancerol Charles Bruneau, Montreal, PQ H3T 1C5, Canada
[5] Hop St Sacrement, Clin Malad Sein Deschenes Fabia, Quebec City, PQ G1S 4L8, Canada
[6] CHUQ, Serv Med Genet, Quebec City, PQ G1V 4G2, Canada
[7] Ctr Hosp Reg Rimouski, Rimouski, PQ G5L 5T1, Canada
[8] Hop Sacre Coeur, Serv Hematooncol, Montreal, PQ H4J 1C5, Canada
[9] Hop Hotel Dieu, CHUQ, Gynecol Serv, Quebec City, PQ G1R 2J6, Canada
[10] WHO, Int Agcy Res Canc, Unit Genet Canc Susceptibil, Lyon, France
[11] Univ Laval, Dept Anat & Physiol, Canada Res Chair Oncogenet, Quebec City, PQ, Canada
关键词
D O I
10.1186/1471-2407-6-230
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ataxia telangiectasia-mutated and Rad3-related (ATR) is a member of the PIK-related family which plays, along with ATM, a central role in cell-cycle regulation. ATR has been shown to phosphorylate several tumor suppressors like BRCA1, CHEK1 and TP53. ATR appears as a good candidate breast cancer susceptibility gene and the current study was designed to screen for ATR germline mutations potentially involved in breast cancer predisposition. Methods: ATR direct sequencing was performed using a fluorescent method while widely available programs were used for linkage disequilibrium (LD), haplotype analyses, and tagging SNP (tSNP) identification. Expression analyses were carried out using real-time PCR. Results: The complete sequence of all exons and flanking intronic sequences were analyzed in DNA samples from 54 individuals affected with breast cancer from non-BRCA1/2 high-risk French Canadian breast/ovarian families. Although no germline mutation has been identified in the coding region, we identified 41 sequence variants, including 16 coding variants, 3 of which are not reported in public databases. SNP haplotypes were established and tSNPs were identified in 73 healthy unrelated French Canadians, providing a valuable tool for further association studies involving the ATR gene, using large cohorts. Our analyses led to the identification of two novel alternative splice transcripts. In contrast to the transcript generated by an alternative splicing site in the intron 41, the one resulting from a deletion of 121 nucleotides in exon 33 is widely expressed, at significant but relatively low levels, in both normal and tumoral cells including normal breast and ovarian tissue. Conclusion: Although no deleterious mutations were identified in the ATR gene, the current study provides an haplotype analysis of the ATR gene polymorphisms, which allowed the identification of a set of SNPs that could be used as tSNPs for large-scale association studies. In addition, our study led to the characterization of a novel. 33 splice form, which could generate a putative truncated protein lacking several functional domains. Additional studies in large cohorts and other populations will be needed to further evaluate if common and/or rare ATR sequence variants can be associated with a modest or intermediate breast cancer risk.
引用
收藏
页数:21
相关论文
共 82 条
[1]   Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway [J].
Alderton, GK ;
Joenje, H ;
Varon, R ;
Borglum, AD ;
Jeggo, PA ;
O'Driscoll, M .
HUMAN MOLECULAR GENETICS, 2004, 13 (24) :3127-3138
[2]  
[Anonymous], CLUSTALW
[3]  
[Anonymous], GENETIC PREDISPOSITI
[4]   A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[5]   BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families [J].
Antoniou, AC ;
Durocher, F ;
Smith, P ;
Simard, J ;
Easton, DF .
BREAST CANCER RESEARCH, 2006, 8 (01)
[6]   A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes [J].
Antoniou, AC ;
Goldgar, DE ;
Andrieu, N ;
Chang-Claude, J ;
Brohet, R ;
Rookus, MA ;
Easton, DF .
GENETIC EPIDEMIOLOGY, 2005, 29 (01) :1-11
[7]   Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Ponder, BAJ ;
Easton, D .
GENETIC EPIDEMIOLOGY, 2001, 21 (01) :1-18
[8]   Partnering in oncogenetic research -: The INHERIT BRCAs experience:: Opportunities and challenges [J].
Avard, D ;
Bridge, P ;
Bucci, L ;
Chiquette, J ;
Dorval, M ;
Durocher, F ;
Easton, D ;
Godard, B ;
Goldgar, D ;
Knoppers, B ;
Laframboise, R ;
Lespérance, B ;
Plante, M ;
Tavtigian, S ;
Vézina, H ;
Wilson, B ;
Simard, J .
FAMILIAL CANCER, 2006, 5 (01) :3-13
[9]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[10]   Contribution of BRCAI and BRCA2 germ-line mutations to the incidence of breast cancer in young women:: Results from a prospective population-based study in France [J].
Bonadona, V ;
Sinilnikova, OM ;
Chopin, S ;
Antoniou, AC ;
Mignotte, H ;
Mathevet, P ;
Brémond, A ;
Martin, A ;
Bobin, JY ;
Romestaing, P ;
Raudrant, D ;
Rudigoz, RC ;
Léoné, M ;
Chauvin, F ;
Easton, DF ;
Lenoir, GM ;
Lasset, C .
GENES CHROMOSOMES & CANCER, 2005, 43 (04) :404-413